Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache
Dr. Bradley Ong discusses the use of eptinezumab in combination with patient education is an effective treatment for reducing disease burden in patients living with chronic migraine complicated by…
Read the full articleYou might also wanna read
Real-world study suggests GLP-1 receptor agonists may reduce emergency visits and medication needs for chronic migraine
Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults w
mdsc.pe·6d ago
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this re-released episode of CME on the Go, originally published on 12/1/2025, our hosts discuss the complexities of diagnosing and treati
GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half
medlink.com·7mo ago
CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds
Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention
mdsc.pe·21d ago
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this episode of CME on the Go, our hosts discuss the complexities of diagnosing and treating headaches in primary care. They cover common
Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
Conditions : Migraine Sponsors : AbbVie Not yet recruiting
Comments
Sign in to join the conversation.
No comments yet. Be the first.